Mannose 6-PHOSPHATE clinical trials
Also written Juvidex and RN1004.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2004
How each study uses mannose 6-PHOSPHATE is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2004 (2)
| Year | Studies |
|---|---|
| 2004 | 2 |
| 2008 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Mannose-6-phosphate (1)
Studies
Open first, then newest update. How each study uses mannose 6-PHOSPHATE is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three TimesCompletedPhase 2RenovoNCT00984516Written as Juvidex
- Investigation Into the Safety of Intradermal Juvidex (M6P) Administered to Wounds of Healthy SubjectsCompletedPhase 1RenovoNCT00984854Written as Juvidex
- Juvidex (Mannose-6-Phosphate) in Accelerating the Healing of Split Thickness Skin Graft Donor SitesCompletedPhase 1/2RenovoNCT00664352Written as Mannose-6-Phophate (Juvidex)